Dublin, Aug. 10, 2016 -- Research and Markets has announced the addition of the "Traumatic Spinal Cord Injury Forecast in 15 Major Markets 2016-2026" report to their offering.
Spinal cord injury is defined as damage to any part of the spinal cord or nerves at the end of the spinal canal, often resulting in permanent changes in strength, sensation and other body functions below the site of the injury. Traumatic spinal cord injury (TSCI) is classified as injury to the spine caused by a traumatic event.
This report provides the current prevalent population for TSCI across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Canada, Netherlands, Australia, South Africa and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains an overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of TSCI have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for TSCI include:
- Deep Vein Thromboses (DVT)
- Urinary Tract Infections (UTI)
- Pressure sores
- Neuropathic pain
- Spasticity
Reason to buy:
- Able to quantify patient populations in global TSCI's market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of TSCI and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on TSCI's prevalent population.
- Identify sub-populations within TSCI which require treatment.
- Gain an understanding of the specific markets that have the largest number of TSCI patients.
Key Topics Covered:
1 List of Tables and Figures
2 Introduction
3 Cause of the Disease
4 Risk Factors & Prevention
5 Diagnosis of the Disease
6 Variation by Geography/Ethnicity
7 Disease Prognosis & Clinical Course
8 Key Co-morbid Conditions/Features Associated with the Disease
9 Methodology for Quantification of Patient Numbers
10 Top-Line Prevalence for Traumatic Spinal Cord Injury
- TSCI by Cause
- Location of TSCI
- Level of Impairment of TSCI
- Sequelae of TSCI
11 Abbreviations used in the Report
12 Patient-Based Offering
13 Online Pricing Data and Platforms
14 References
15 Appendix
For more information visit http://www.researchandmarkets.com/research/sqzcsv/traumatic_spinal
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 



